You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cc-486

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 15, 2022

AML Trial in Aurora (Venetoclax, CC-486)

Recruiting
  • AML
  • Aurora, Colorado
  • +1 more
Apr 4, 2022

Follicular Lymphoma Trial in Chicago (Venetoclax, Obinutuzumab, CC-486)

Recruiting
  • Follicular Lymphoma
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Australia (Azacitidine, CC-486)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
Mar 29, 2022

Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

Active, not recruiting
  • Hematologic Neoplasm
  • Neoplasms
  • CC-486
  • Gainesville, Florida
  • +2 more
Dec 2, 2021

Acute Myelogenous Leukemia (AML) Trial in Summit (CC-486)

Approved for marketing
  • Acute Myelogenous Leukemia (AML)
  • CC-486
  • Summit, New Jersey
    Celgene
Sep 16, 2020

Leukemia, Myeloid, Acute Trial in China (CC-486, Placebo)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • CC-486
  • Placebo
  • Hefei, Anhui, China
  • +31 more
Jun 7, 2022

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • CC-486
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

NSCLC Trial in Worldwide (CC-486, Pembrolizumab, Placebo)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • CC-486
  • +2 more
  • Glendale, Arizona
  • +32 more
Jan 21, 2022

NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • nab-paclitaxel IV
  • +2 more
  • San Francisco, California
  • +33 more
Jan 24, 2022

Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
Apr 6, 2022

Urinary Bladder Tumors, Carcinoma, Transitional Cell, Ovarian Tumors Trial in Worldwide (CC-486, Carboplatin, ABI-007)

Completed
  • Urinary Bladder Neoplasms
  • +7 more
  • CC-486
  • +2 more
  • Scottsdale, Arizona
  • +12 more
Nov 7, 2019

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • CC-486
  • New York, New York
  • +4 more
Oct 22, 2018

Nasopharyngeal Tumors Trial in Worldwide (CC-486)

Completed
Has Results
  • Nasopharyngeal Neoplasms
  • CC-486
  • Atlanta, Georgia
  • +24 more
Nov 20, 2018

Breast Tumors Trial in Worldwide (CC-486, Fulvestrant)

Terminated
Has Results
  • Breast Neoplasms
  • Chandler, Arizona
  • +34 more
Dec 12, 2018